6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death
- PMID: 7583676
- DOI: 10.1006/neur.1995.0016
6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death
Abstract
The 6-hydroxydopamine (6-OHDA) model of nigral injury in rats has been in use as a standard animal model of parkinsonism for many years. While earlier studies established the time course for loss of catecholamine histofluorescence or tyrosine hydroxylase immunostaining in the cell bodies and terminals, these alterations in phenotypic expression do not define the time course of morphologic degeneration. We have therefore used a silver impregnation method to characterize the time course and morphology of the degeneration of neurons in the nigrostriatal system. Abundant neuronal death was observed in substantia nigra pars compacta (SNpc) as early as 12 hours after nigral 6-OHDA injection, and prior to any evidence of striatal terminal degeneration. From 1 to 7 days neuron death was accompanied by striatal fibre degeneration. After 7 days, fibre degeneration was no longer seen, but identifiable neuron death continued at low levels for as long as 31 days, and stained amorphous material was present at 60 days. The morphologic pattern of cell death in the early phase was similar to that in the late phase, and included cytoplasmic silver deposits and dark staining of the nucleolus. At no time was the morphology of apoptosis observed. We conclude that neuron death is a progressive process following 6-OHDA lesion, with similar morphology throughout the course of degeneration.
Similar articles
-
Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death.Neuroscience. 1996 Oct;74(4):997-1008. doi: 10.1016/0306-4522(96)00175-3. Neuroscience. 1996. PMID: 8895868
-
Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion.J Comp Neurol. 2000 Nov 20;427(3):440-54. doi: 10.1002/1096-9861(20001120)427:3<440::aid-cne10>3.0.co;2-7. J Comp Neurol. 2000. PMID: 11054705
-
Extracellular Zn2+ Influx into Nigral Dopaminergic Neurons Plays a Key Role for Pathogenesis of 6-Hydroxydopamine-Induced Parkinson's Disease in Rats.Mol Neurobiol. 2019 Jan;56(1):435-443. doi: 10.1007/s12035-018-1075-z. Epub 2018 Apr 29. Mol Neurobiol. 2019. PMID: 29705946
-
Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease.Mol Ther. 2011 Jan;19(1):46-52. doi: 10.1038/mt.2010.217. Epub 2010 Oct 19. Mol Ther. 2011. PMID: 20959812 Free PMC article.
-
Neuropathology of the substantia nigra.Eur Neurol. 1991;31 Suppl 1:48-59. doi: 10.1159/000116721. Eur Neurol. 1991. PMID: 1830274 Review.
Cited by
-
Aging, Parkinson's Disease, and Models: What Are the Challenges?Aging Biol. 2023;1:e20230010. doi: 10.59368/agingbio.20230010. Epub 2023 Jul 28. Aging Biol. 2023. PMID: 38978807 Free PMC article.
-
Quantifying muscle alterations in a Parkinson's disease animal model using electromyographic biomarkers.Med Biol Eng Comput. 2021 Sep;59(9):1735-1749. doi: 10.1007/s11517-021-02400-3. Epub 2021 Jul 23. Med Biol Eng Comput. 2021. PMID: 34297299
-
Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine.Exp Neurol. 2023 Nov;369:114522. doi: 10.1016/j.expneurol.2023.114522. Epub 2023 Aug 26. Exp Neurol. 2023. PMID: 37640098 Free PMC article.
-
Evaluation of Models of Parkinson's Disease.Front Neurosci. 2016 Jan 19;9:503. doi: 10.3389/fnins.2015.00503. eCollection 2015. Front Neurosci. 2016. PMID: 26834536 Free PMC article. Review.
-
Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats.Brain Res. 2023 Jul 15;1811:148381. doi: 10.1016/j.brainres.2023.148381. Epub 2023 Apr 29. Brain Res. 2023. PMID: 37127174 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous